Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
4.780
-0.190 (-3.82%)
May 15, 2026, 11:11 AM EDT - Market open
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $341.3 million as of May 15, 2026. Its market cap has increased by 1,037.83% in one year.
Market Cap
341.30M
Enterprise Value
296.11M
1-Year Change
1,037.83%
Ranking
Category
Stock Price
$4.78
Market Cap Chart
Since September 25, 2024, Opus Genetics's market cap has increased from $33.73M to $341.30M, an increase of 911.96%. That is a compound annual growth rate of 312.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 4.32B | 3,290.08% |
| Dec 31, 2025 | 127.39M | 305.02% |
| Dec 31, 2024 | 31.45M | -6.75% |
| Sep 25, 2024 | 33.73M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rocket Pharmaceuticals | 371.26M |
| Puma Biotechnology | 365.97M |
| Neumora Therapeutics | 359.90M |
| Greenwich LifeSciences | 359.80M |
| Compass Therapeutics | 356.57M |
| YD Bio | 355.82M |
| Rezolute | 355.19M |
| InflaRx | 350.56M |